NDC11 79952011001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 79952-0110-01 | 79952-0110 |
| 79952-0110-1 | 79952-0110 |
| 79952-110-01 | 79952-110 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZYNLONTA | LONCASTUXIMAB TESIRINE | ADC Therapeutics America, Inc. | af54af12-3edf-4301-8bc5-0446bc813c1d | 2026-06-12 | Warnings, Adverse reactions | 79952-110-01 79952-110 79952011001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.